CDK16 and cancer: In the univariate Cox regression analysis (UniCox), CDK16 emerged as a significant risk factor for overall survival (OS) in a range of cancers, namely LIHC, LGG, PCPG, KIRC, UCEC, UVM, BRCA, and MESO (Figure 3A).